thymidine monophosphate has been researched along with Adenocarcinoma of Lung in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, X; Dong, M; Liu, Y; Lv, Y; Shi, Y; Wang, H; Yang, J; Zhang, Y; Zhang, Z; Zuo, X | 1 |
| Chen, X; Ding, X; Huang, X; Jiang, X; Niu, X; Pu, J; Yuan, Y; Zhou, F | 1 |
| Chen, Y; Lai, F; Lin, J; Lin, N; Qiu, R; Yin, Y; Yu, F; Zhuo, Y | 1 |
3 other study(ies) available for thymidine monophosphate and Adenocarcinoma of Lung
| Article | Year |
|---|---|
Comprehensive analysis of DTYMK in pan-cancer and verification in lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Biomarkers, Tumor; Humans; Lung Neoplasms; Thymidine Monophosphate | 2022 |
Comprehensive analysis of DTYMK for estimating the immune microenvironment, diagnosis, prognosis effect in patients with lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Biomarkers; Humans; Lung Neoplasms; Prognosis; Thymidine Monophosphate; Tumor Microenvironment | 2022 |
Knockdown of deoxythymidylate kinase suppresses progression and epithelial-mesenchymal-transition of lung adenocarcinoma via STAT3 signaling.
Topics: Adenocarcinoma of Lung; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Lung; Lung Neoplasms; Signal Transduction; STAT3 Transcription Factor; Thymidine Monophosphate | 2023 |